Brenda Cordell

About Brenda Cordell

Brenda Cordell is a Senior Healthcare Consultant in the Indianapolis Health Practice of Milliman. She joined the firm in 2008 and is a lead in Milliman\'s life sciences consulting group. Brenda is also co-creator of Milliman DNA Gene and Cell Therapy Forecasting, a dynamic, web-­based application that estimates the associated costs and cases for approved and pipeline gene and cell therapies. Brenda leads the clinical, market and economic research that form the baseline assumptions in this application and its associated research repository. With over 25 years of experience in leadership roles within life sciences companies and at Milliman, Brenda\'s focus areas are market access, payer strategy, market intelligence and financial analysis specifically in rare disease and novel therapies. Brenda has authored several white papers and reports, some of which have been published by the Journal of Managed Care & Specialty Pharmacy (JMCSP). She has also presented at AMCP and Self-Insurance Institute of America (SIIA). She is a member of the SIIA Cell & Gene Therapy Task Force.

Experience

1. Senior Healthcare Consultant

   Milliman

   Mar 2008 — Present

   Professional Speaking Engagements:Presentation Topic:\"Pricing for Life: Customer Behavior and Lifetime Analysis\"Conference: The 21st Annual Price X EventLocation/Date: Chicago, IL ( June 9 - 11, 2008)Audience: Pricing practitioners and high level executives with responsibilities in strategic planning, marketing, branding, new product development and financial management from multiple industries (including healthcare)Presentation Topic:\"The US Pharmaceutical Pricing and Access Environment for Retail Products\"Conference: 4th Annual Pharmaceutical Pricing & Reimbursement Location: New Brunswick, NJ (July 17 & 18, 2008)Meeting Date: July 17 & 18Audience: Management/employees of pharmaceutical companies with pricing and reimbursement responsibilitiesAreas of Focus -Using Market Models to Improve Pricing and Contracting Decisions-Improving understanding of formulary access and driving market share-Addressing messaging to formulary decision makerPresentation Topic:\"Optimizing Pharmaceutical Value to Support Favorable Formulary Positions\" Conference: Milliman 2010 Health Form Location/Date: Orlando, FL (March 2010)PUBLICATIONS:

Education

• The Ohio State University Fisher College of Business

  MBA

  1997 — 1999

• University of Northern Iowa

  BA

  1987 — 1991

Skills

• Health Policy
• Strategic Planning
• Healthcare
• Strategy
• Idns
• Market Research
• Cross-Functional Team Leadership
• Marketing Strategy
• Marketing
• Pharmaceutical Industry
• Health Economics
• Pharmacy Benefit Management
• Pricing Strategy
• Mcos
• Biotechnology Industry
• Pricing
• Value Propositions
• Finance
• Health Care Reform
• Product Development
• Product Management
• Analysis
• Managed Care
• Product Launch
• Segmentation